Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Are there height-dependent differences in subclinical vascular disease in hypertensive patients?

Ferriol C, Tremols S, Jimenez C, Tura A, Sanmartín M, Pagès N, Rodríguez-Poncelas A, Paz-Bermejo M, Saez M, Coll-de-Tuero G.

J Clin Hypertens (Greenwich). 2014 Jan;16(1):70-6. doi: 10.1111/jch.12222. Epub 2013 Nov 5.

2.

Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.

Nardi E, Palermo A, Mulè G, Cusimano P, Cerasola G, Rini GB.

Eur J Prev Cardiol. 2013 Oct;20(5):854-61. doi: 10.1177/2047487312447845. Epub 2012 May 3.

PMID:
22556375
3.
4.

Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.

Redón J, Cea-Calvo L, Lozano JV, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J; ERIC-HTA 2003 Study Investigators.

J Hypertens. 2006 Apr;24(4):663-9.

PMID:
16531794
5.

Evolution of target organ damage by different values of self-blood pressure measurement in untreated hypertensive patients.

Coll-de-Tuero G, Saez M, Roca-Saumell C, Rodriguez-Poncelas A, Franco P, Dalfó A, Calvó-Perxas L, Pose-Reino A, Bayó-Llibre J.

Am J Hypertens. 2012 Dec;25(12):1256-63. doi: 10.1038/ajh.2012.126. Epub 2012 Aug 23.

PMID:
22914254
6.

The relationship between microalbuminuria, left ventricular hypertrophy, retinopathy, and sex hormone status in newly diagnosed hypertensive women.

Apikoglu M, Bulucu F, Demirbas S, Ay SA, Karaman M, Altun B, Balta S, Gokce G, Demirkol S, Yaman H, Saglam K.

Clin Exp Hypertens. 2013;35(5):325-9. doi: 10.3109/10641963.2012.721844. Epub 2012 Sep 5.

PMID:
22950595
7.

[Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].

González-Juanatey JR, Cea-Calvo L, Bertomeu V, Aznar J; for Investigators study VIIDA.

Rev Esp Cardiol. 2007 Feb;60(2):148-56. Spanish.

8.

Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7).

Cuspidi C, Giudici V, Negri F, Meani S, Sala C, Zanchetti A, Mancia G.

J Hypertens. 2009 Dec;27(12):2465-71. doi: 10.1097/HJH.0b013e32833105a6.

PMID:
19898252
9.

The determinants of left ventricular hypertrophy defined by Sokolow-Lyon criteria in untreated hypertensive patients.

Antikainen R, Grodzicki T, Palmer AJ, Beevers DG, Coles EC, Webster J, Bulpitt CJ.

J Hum Hypertens. 2003 Mar;17(3):159-64.

PMID:
12624605
10.

Prevalence of left ventricular hypertrophy as assessed by electrocardiogram in treated hypertensive persons in general practice.

van den Hoogen JP, van Kruijsdijk MC, van Ree JW, Mokkink HG, Thien T, van Weel C.

J Hum Hypertens. 1993 Oct;7(5):473-7.

PMID:
8263888
11.

Clinical correlates of left ventricular hypertrophy in black patients with arterial hypertension.

Lepira FB, Kayembe PK, M'buyamba-Kabangu JR, Nseka MN.

Cardiovasc J S Afr. 2006 Jan-Feb;17(1):7-11.

12.

[Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].

Grabysa R, Cholewa M.

Pol Merkur Lekarski. 2008 Oct;25(148):309-14. Polish.

PMID:
19145927
13.

Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.

Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Porcellati C.

J Am Coll Cardiol. 1998 Feb;31(2):383-90.

14.

[Association between hypertensive left ventricular hypertrophy and cardiovascular events in adult Beijing residents: a cohort study].

Li Y, Zhao D, Liu J, Li CF, Guo W, Chen CH, Hao P, Sun JY, Qin LP, Wang W.

Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Nov;36(11):1037-42. Chinese.

PMID:
19102921
15.

Arterial hypertension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population.

Shipilova T, Pshenichnikov I, Kaik J, Volozh O, Abina J, Kalev M, Lass J, Karai D.

Blood Press. 2003;12(1):12-8.

PMID:
12699130
16.

[Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].

Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J.

Rev Esp Cardiol. 2006 Feb;59(2):136-42. Spanish.

17.
18.

Hypertensive retinopathy and its association with cardiovascular, renal and cerebrovascular morbidity in Congolese patients.

Kabedi NN, Mwanza JC, Lepira FB, Kayembe TK, Kayembe DL.

Cardiovasc J Afr. 2014 Sep-Oct;25(5):228-32. doi: 10.5830/CVJA-2014-045.

19.

Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review.

Cuspidi C, Rescaldani M, Sala C, Negri F, Grassi G, Mancia G.

J Hypertens. 2012 Nov;30(11):2066-73. doi: 10.1097/HJH.0b013e32835726a3. Review.

PMID:
22914541
20.

Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study.

Cuspidi C, Meani S, Valerio C, Fusi V, Catini E, Sala C, Magrini F, Zanchetti A.

Blood Press. 2005;14(1):25-31.

PMID:
15823944

Supplemental Content

Support Center